13F-HR filed by Propel Bio Management, LLC
Propel Bio Management, LLC filed this 13F-HR for the quarter ended 2024-09-30, filed 2024-11-13, with 21 holding rows worth $172,410,614.
- Accession
- 0001829126-24-007453
- Filer
- CIK 1969764
- Filed
- 2024-11-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2024
A holdings report, 21 entries on the cover page, a total value of $172,410,614 stated on the cover page (in dollars after the unit check, H1), rows summing to $172,410,614 with VALUE read as dollars as filed, 13F file number 028-23914. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerSimplify Asset Management Inc.028-20937
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| Applied Therapeutics Inc | 03828A101 | Common Stock | 6,567,858 | $55,826,793 | dollars as filed | |
| PLAINS GP HLDGS L P | 72651A207 | LTD PARTNR INT A | 1,272,360 | $23,538,660 | dollars as filed | |
| PHATHOM PHARMACEUTICALS INC | 71722W107 | COMMON STOCK | 869,927 | $15,728,280 | dollars as filed | |
| ACHIEVE LIFE SCIENCES INC | 004468500 | COMMON STOCK | 2,453,092 | $11,627,656 | dollars as filed | |
| Tscan Therapeutics Inc | 89854M101 | COM | 2,087,139 | $10,393,952 | dollars as filed | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 343,729 | $9,861,585 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 43,032 | $9,132,251 | dollars as filed | |
| AVIDITY BIOSCIENCES INC COM | 05370A108 | Stock | 178,500 | $8,198,505 | dollars as filed | |
| ARDELYX INC | 039697107 | COM | 1,070,947 | $7,378,825 | dollars as filed | |
| TELESAT CORP | 879512309 | CL A & CL B SHS | 365,781 | $4,817,336 | dollars as filed | |
| ABEONA THERAPEUTICS INC | 00289Y206 | COM NEW | 624,022 | $3,943,819 | dollars as filed | |
| KYMERA THERAPEUTICS INC | 501575104 | COM | 56,359 | $2,667,471 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 133,259 | $2,565,236 | dollars as filed | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 130,000 | $2,540,200 | dollars as filed | |
| ZEVRA THERAPEUTICS INC COM NEW | 488445206 | Stock | 179,874 | $1,248,326 | dollars as filed | |
| EIGER BIOPHARMACEUTICALS | 28249U204 | COMM | 146,381 | $1,244,239 | dollars as filed | |
| ATHIRA PHARMA INC | 04746L104 | COM | 1,492,792 | $665,785 | dollars as filed | |
| COMPASS PATHWAYS PLC | 20451W101 | SPONSORED ADS | 80,000 | $504,000 | dollars as filed | |
| VERRICA PHARMACEUTICALS INC | 92511W108 | COM | 344,937 | $500,159 | dollars as filed | |
| MAAT PHARMA SACA | F5888J116 | COMM | 2,397 | $17,786 | dollars as filed | |
| CHINOOK THERAPEUTICS CVR | 169CVR016 | RIG | 79,357 | $9,750 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001829126-24-007453 | this filing | 2024-11-13 | acceptance time not in the bulk data set |